HaemaLogiX Advances KMCAR™ T-Cell Clinical Program
SYDNEY, Australia, August 26, 2026 HaemaLogiX Ltd has announced a key clinical development milestone with the first patient successfully...
CAR-T therapy
Advertisement
Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs
August 24, 2026 | San Jose, California Anixa Biosciences announced that it will present updates on its breast cancer...
Anixa Biosciences Advances Ovarian Cancer CAR-T to Highest Dose
SAN JOSE, California, July 6, 2026 Anixa Biosciences, Inc. and Moffitt Cancer Center have announced a significant milestone in...
Anixa Biosciences Reports Positive Phase 1 Cancer Vaccine Data
June 26, 2026 | San Jose, California, USA Anixa Biosciences, Inc. announced encouraging clinical updates from its two leading...
Qihan Biotech’s QT-019B Earns FDA RMAT and Breakthrough Therapy Designations
HANGZHOU, China, June 11, 2026 Qihan Biotech announced that its investigational universal dual-target CAR-T therapy QT-019B has received both...
Advertisements
Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
Anixa Biosciences Highlights Clinical Immunotherapy Progress at Cancer Symposium
SAN JOSE, Calif., June 11, 2026 Anixa Biosciences, Inc. announced that two of its clinical-stage cancer immunotherapy programs will...
Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Eti-cel Data at EHA 2026
NEW YORK, NY, June 11, 2026 Cellectis announced final Phase 1 results from the BALLI-01 clinical trial evaluating lasme-cel,...
Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval
BOSTON, June 9, 2026 Imviva Biotech announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational...
Advertisement
